Analysing today’s increasingly large and heterogeneous biotherapeutics remains a major challenge for drug developers, ...
Spectronaut® 19 offers significant improvements in identifications, candidate discovery, scalability for large-scale analysis, and support for novel workflows Novel TrueDiscovery® P2 Plasma Enrichment ...